Institute of Psychiatry, Psychology & Neuroscience

Pharmacological imaging

We study the effect of drugs on the nervous system, vital for the development of new treatments for disorders and diseases of the central nervous system. Working closely with industry partners, we show researchers whether drugs are engaging with their targets. We also develop pioneering methodologies and analytics for collaborators. Our unique location in the Institute of Psychiatry, Psychology and Neuroscience supports our research into how drugs change the way we think and behave.

There is vast potential for new drugs, which need rigorous safety testing. By enabling the safe testing of novel compounds we support researchers to find out whether drugs reach their targets and how they affect brain cells. This provides vital information on the safety and effectiveness of new drugs that could dramatically improve the lives of patients.

Click people profiles to discover their research:

Dr Diana Cash

Senior Lecturer in Preclinical Neuroimaging
Dr Vasileia Kotoula

Lecturer in Neuroscience and Psychology
Dr Laura Mantoan Ritter

Consultant Neurologist and Adjunct Reader
Professor Mitul Mehta

Director, Centre for Innovative Therapeutics
Dr Owen O'Daly

Senior Lecturer
Dr Yannis Paloyelis

Reader in Neuroscience and Psychology
Dr Sonja Pyott

Senior Lecturer
Dr Eugenii Rabiner

Reader in Molecular Neuroimaging
Professor Mark Richardson

Head of School (Neuroscience)
Professor Deepak Srivastava

Professor of Molecular Neuroscience
Dr James Stone

Clinical Senior Lecturer
Professor Federico Turkheimer

Professor in Neuroimaging (Analysis & Statistics)
Professor Anthony Vernon

Professor of Neuropsychopharmacology
Professor Steve Williams

Professor of Neuroimaging
Dr Toby Wise

Senior Research Fellow